FDA Advisers Vote Against Pfizer-BioNTech Booster Shot

Sep.17 — A U.S. Food and Drug Administration panel of expert advisers voted against a third dose of the Pfizer Inc.-BioNTech SE vaccine for everyone 16 and older on Friday. Bloomberg’s Angelica LaVito has the latest on “Bloomberg Markets: The Close.”